Fig. 3From: An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism a Mean (±SD) percentage of progressively motile sperm during the combined treatment phase; b Mean (±SD) percentage of normal morphology sperm during the combined treatment phaseBack to article page